Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 495 | 684 |
| Cost of Goods | N/A | 0 | 2 | 394 | 502 |
| Gross Profit | N/A | 0 | -2 | 101 | 182 |
| Operating Expenses | 669 | 1,364 | 2,418 | 5,224 | 4,021 |
| Operating Income | -669 | -1,364 | -2,421 | -5,123 | -3,839 |
| Interest Expense | 274 | 334 | 223 | 156 | 352 |
| Other Income | 69 | -12,574 | -610 | -1,427 | -1,712 |
| Pre-tax Income | -873 | -14,273 | -3,254 | -6,707 | -5,903 |
| Income Tax | 0 | -1,010 | -190 | -834 | -389 |
| Net Income Continuous | -873 | -13,262 | -3,064 | -5,874 | -5,514 |
| Net Income Discontinuous | N/A | 0 | -5,812 | N/A | N/A |
| Minority Interests | 80 | 61 | N/A | 247 | 295 |
| Net Income | $-793 | $-13,201 | $-8,876 | $-5,626 | $-5,219 |
| EPS Basic Total Ops | -0.01 | -0.23 | -0.18 | -0.13 | -0.27 |
| EPS Basic Continuous Ops | -0.01 | -0.23 | -0.06 | -0.13 | -0.27 |
| EPS Basic Discontinuous Ops | N/A | 0.00 | -0.12 | N/A | N/A |
| EPS Diluted Total Ops | -0.01 | -0.23 | -0.18 | -0.13 | -0.27 |
| EPS Diluted Continuous Ops | -0.01 | -0.23 | -0.06 | -0.13 | -0.27 |
| EPS Diluted Discontinuous Ops | N/A | 0.00 | -0.12 | N/A | N/A |
| EBITDA(a) | $-549 | $-13,912 | $-3,010 | $-5,268 | $-4,254 |